| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |